Pharmaceuticals
What are the latest products in the pipeline of the world’s leading drug companies? How are the pharmaceutical giants and key niche players performing financially – in terms of stock performance, share value, price ratios, etc.? What are the latest deals, alliances and agreements among drug developers and manufacturers? These are just some of the questions answered by the following extensive selection of in-depth pharmaceutical company profiles. Examine the market strategy, organisational structure
and product range performance of the likes of Procter & Gamble, Merck & Co, Eli Lilly, Pfizer, GlaxoSmithKline, Novartis and Bayer Schering. Numerous SWOT (Strengths, Weaknesses, Opportunities and Threats) company reports are also listed.
Show Less
Read more
Genitourinary Partnering Yearbook 2013
The Genitourinary Partnering Yearbook 2013 report series provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare...
January
2013
FROM
EUR 1,143USD 1,495GBP 964AUD 1,591JPY 146,413SEK 9 899CHF 1'407CAD 1,555
Practical Guide to Finding Partners
Current Partnering’s Practical Guide to Finding Partners provides a comprehensive overview of all the steps required to identify and secure potential partnering opportunities either for an in-licensing...
January
2013
FROM
EUR 991USD 1,295GBP 835AUD 1,378JPY 126,826SEK 8 575CHF 1'219CAD 1,347
Pharmaceutical Partnering Yearbook 2013
The Pharmaceutical Partnering Yearbook 2013 report series provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare...
January
2013
FROM
EUR 1,143USD 1,495GBP 964AUD 1,591JPY 146,413SEK 9 899CHF 1'407CAD 1,555
Arcadia Resources Inc.,(KADR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Arcadia Resources Inc. (KADR), plus vital industry benchmarks and extensive operating ratios, along with...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
AtCor Medical Holdings Limited,(AMDHF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for AtCor Medical Holdings Limited (AMDHF), plus vital industry benchmarks and extensive operating ratios, along...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Baxter International Inc,(BAX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Baxter International Inc (BAX), plus vital industry benchmarks and extensive operating ratios, along with...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Atrion Corporation,(ATRI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Atrion Corporation (ATRI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Avitar, Inc.,(AVTI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Avitar, Inc. (AVTI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
ArQule Inc,(ARQL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for ArQule Inc (ARQL), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
ArthroCare Corp,(ARTC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for ArthroCare Corp (ARTC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Assurant Inc,(AIZ) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Assurant Inc (AIZ), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
AstraZeneca plc,(AZN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for AstraZeneca plc (AZN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Athenahealth Inc,(ATHN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Athenahealth Inc (ATHN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Banyan Corporation,(BNYN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Banyan Corporation (BNYN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Astellas Pharma Inc,(ALPMY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Astellas Pharma Inc (ALPMY), plus vital industry benchmarks and extensive operating ratios, along with an...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
AtriCure, Inc.,(ATRC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for AtriCure, Inc. (ATRC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
AxoGen Inc,(AXGN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for AxoGen Inc (AXGN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Arrhythmia Research Technology,(HRT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Arrhythmia Research Technology (HRT), plus vital industry benchmarks and extensive operating ratios, along...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Assisted Living Concepts Inc.,(ALC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Assisted Living Concepts Inc. (ALC), plus vital industry benchmarks and extensive operating ratios, along...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
Integra Lifesciences Holdings Corp,(IART) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
Why You Should Buy This Report:
A value-packed package of corporate financial analysis, for Integra Lifesciences Holdings Corp (IART), plus vital industry benchmarks and extensive operating ratios,...
December
2012
FROM
EUR 76USD 99GBP 64AUD 105JPY 9,696SEK 656CHF 93CAD 103
